•This study elucidates the role of TRIP13 on molecular level, as a specific signal for early events of pancreatic cancer, enhancing patient prognosis, and boosting targeted therapies in clinical settings. This evidence concerns the gene TRIP13 and familial pancreatic carcinoma.